Skip to main content
United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
569.11
+2.12 (0.37%)
At close: Apr 28, 2026, 4:00 PM EDT
573.88
+4.77 (0.84%)
Pre-market: Apr 29, 2026, 4:21 AM EDT

United Therapeutics Revenue

In the year 2025, United Therapeutics had annual revenue of $3.18B with 10.61% growth. United Therapeutics had revenue of $790.20M in the quarter ending December 31, 2025, with 7.38% growth.

Revenue (ttm)
$3.18B
Revenue Growth
+10.61%
P/S Ratio
7.84
Revenue / Employee
$2,273,357
Employees
1,400
Market Cap
24.94B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20253.18B305.30M10.61%
Dec 31, 20242.88B549.90M23.63%
Dec 31, 20232.33B391.20M20.20%
Dec 31, 20221.94B250.80M14.88%
Dec 31, 20211.69B202.20M13.63%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Takeda Pharmaceutical Company 28.48B
Teva Pharmaceutical Industries 17.26B
Haleon 14.85B
Viatris 14.30B
Zoetis 9.47B
Elanco Animal Health 4.72B
Dr. Reddy's Laboratories 3.85B
Neurocrine Biosciences 2.86B
Revenue Rankings

UTHR News

More News